Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics.

Preview text: Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics. Insu Therapeutics…

Friday, Aug 7, 2026 at 3:44 PM EasternMailchimp

Victory Square TechnologiesInsu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics.

Image not available

No image available for this email.

Subject: Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics.
Preview text: Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics. Insu Therapeutics…
From: ir@victorysquare.com
Brand: Victory Square Technologies
ESP: Mailchimp
Sent: Fri Aug 7, 2026, 3:44 PM ET
Sent to: victorysquare.com
Size: 63 KB
Images: 5
Links: 7, 2 of them buttons
Subject length: 70 characters

Against Victory Square Technologies's usual

Sent in the 3 PM hour, which holds 25% of its emails; 38% arrive in the 9 AM hour. The subject is 70 characters; its average is 83.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Victory Square Technologies <[email protected]>
Reply-To: Victory Square Technologies <[email protected]>
Subject: Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics.
Date: Fri, 7 Aug 2026 19:44:03 +0000
Message-ID domain: mail101.atl231.mcsv.net
Return-Path domain: mail101.atl231.mcsv.net
DKIM signature: d=victorysquare.com s=k3
List-Unsubscribe: Present, one-click
Mailer: Mailchimp Mailer
Feedback-ID sender: mc

from mail101.atl231.mcsv.net [198.2.141.101] by our receiving server with ESMTPS
from localhost [127.0.0.1] by mail101.atl231.mcsv.net with ESMTP

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Oct 13, 2026 9:00 AM	VST Webinar Replay: Your Questions. Our Strategy. What Comes Next.
	Oct 8, 2026 7:40 AM	A Big Milestone for VST: Insu’s Needle-Free Platform Gains U.S. Patent Allowance
	Oct 6, 2026 9:00 AM	Victory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail’s 2026 Canada’s Top Growing Companies List
	Sep 28, 2026 3:45 PM	October 8: VST Portfolio Update and Live Shareholder Q&A
	Sep 14, 2026 9:14 PM	Portfolio Update: A Deeper Look at Hydreight’s Growth Engine
	Sep 1, 2026 9:55 AM	Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million
	Aug 7, 2026 3:44 PM	Insu Therapeutics Webinar Replay: One Platform. Multiple Therapeutics. (this email)